Structure and Function of Eukaryotic Phosphatidylserine Decarboxylase
真核磷脂酰丝氨酸脱羧酶的结构和功能
基本信息
- 批准号:8706914
- 负责人:
- 金额:$ 30.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressArachidonic AcidsAutophagocytosisBacteriaBehaviorBindingBinding SitesBiochemicalBiological MetamorphosisC-terminalCarboxy-LyasesCell divisionCell membraneCellsComplementary DNACoupledDataDetergentsEmbryoEnzyme PrecursorsEnzymesEscherichia coliEukaryotaEventFamilyGene SilencingGeneticGenetic TranscriptionGrowthHumanIn VitroIndividualIntegral Membrane ProteinLeukotrienesLipidsMammalian CellMembraneMembrane LipidsMitochondriaModelingMolecularMusN-terminalOrganellesOrganismParasitesPathway interactionsPeptide HydrolasesPhosphatidic AcidPhosphatidylethanolaminePhosphatidylglycerolsPhosphatidylinositolsPhosphatidylserinesPhospholipid MetabolismPhospholipidsPlasmodium knowlesiPlayPopulationPost-Translational Protein ProcessingPost-Translational RegulationProcessProductionProkaryotic CellsPropertyProstaglandinsProsthesisProtein IsoformsProteolysisPyruvateReactionRegulationRelative (related person)ResearchRetinaldehydeRoleSerine ProteaseSiteSourceStructureSystemSystems AnalysisTestingTissuesTranslationsWorkenzyme activityfungusinsightinterestlipid metabolismmembermembrane biogenesismolecular rearrangementnovelpathogenpolypeptidepublic health relevancevisual cycle
项目摘要
DESCRIPTION (provided by applicant): Phosphatidylethanolamine (PE) is an essential lipid in organisms ranging from bacteria to humans and a pivotal enzyme in the production of this phospholipid is phosphatidylserine decarboxylase (PSD). Although the deduced primary structure of eukaryotic PSD has been known for more than a decade, the details about how the activity of this enzyme is regulated have been elusive. In addition, PSD belongs to an unusual family of enzymes that contain a pyruvoyl prosthetic group. Progress in understanding eukaryotic PSD enzymes has been hampered by its integral membrane structure and relative lability in the presence of detergents. Recently, we cloned a cDNA encoding PSD from the parasite Plasmodium knowlesi (PkPSD). The PkPSD exists in both soluble and membrane bound forms. The availability of soluble forms of PkPSD has now enabled new lines of inquiry into the structure and function of this enzyme. Using coupled in vitro transcription/ translation systems we have begun to dissect the early events that regulate the conversion of nascent proenzyme to the mature enzyme, consisting of a small ¿-subunit containing the pyruvoyl prosthetic group, and a large ¿-subunit. We have now devised a system for examining the in vitro processing of the proenzyme to the mature enzyme, and have succeeded in expressing high levels of the proenzyme in bacteria. Utilizing these systems we now plan to conduct experimentation to elucidate the mechanisms of proenzyme processing and post translational regulation of catalytic activity. This work will be undertaken in a research plan containing three Specific Aims. The first Specific Aim will test the hypothesis that the PkPSD proenzyme is initially a serine protease that undergoes a molecular metamorphosis to become a decarboxylase. The protease activity of the proenzyme is proposed to be activated by phosphatidylserine and inhibited by phosphatidylglycerol, phosphatidylinositol and phosphatidic acid. The second Specific Aim will examine the lipid regulation of the PkPSD by testing for the presence of specific phospholipid binding sites. The third Specific Aim will investigate the hypothesis that lipid regulation of PkPSD is mechanistically coupled to proenzyme processing by inducing conformational changes to the enzyme that either activate or inhibit the protease function. From these studies we will obtain a comprehensive view of how the lipid composition of cell membranes allosterically influences the activation of an essential enzyme in phospholipid synthesis. Understanding this aspect of PSD regulation coupled to membrane lipid composition will have important consequences for intervening in phospholipid metabolism of pathogens and mammalian cells with unregulated growth.
性状(由申请人提供):磷脂酰乙醇胺(PE)是从细菌到人类的生物体中的一种必需脂质,该磷脂生产中的关键酶是磷脂酰丝氨酸脱羧酶(PSD)。虽然真核PSD的推导的一级结构已经知道了十多年,关于这种酶的活性是如何调节的细节一直难以捉摸。此外,PSD属于一个不寻常的酶家族,含有一个异戊酰辅基。了解真核PSD酶的进展一直受到其完整的膜结构和相对不稳定性的洗涤剂的存在下。最近,我们克隆了一个cDNA编码PSD的寄生虫诺氏疟原虫(PkPSD)。PkPSD以可溶性和膜结合形式存在。可溶性形式的PkPSD的可用性现在已经使对这种酶的结构和功能的新的研究成为可能。使用耦合在体外转录/翻译系统,我们已经开始解剖的早期事件,调节新生的酶原转化为成熟的酶,包括一个小的<$-亚基含有的异戊酰辅基,和一个大亚基。我们现在已经设计了一个系统,用于检查在体外加工的酶原成熟的酶,并已成功地在细菌中表达高水平的酶原。利用这些系统,我们现在计划进行实验,以阐明酶前加工和翻译后调节催化活性的机制。这项工作将在一项包含三个具体目标的研究计划中进行。第一个具体目标将测试PkPSD酶原最初是一种丝氨酸蛋白酶,经过分子变态成为脱羧酶的假设。酶原的蛋白酶活性被提议由磷脂酰丝氨酸激活并由磷脂酰甘油、磷脂酰肌醇和磷脂酸抑制。第二个特定目的将通过检测是否存在特异性磷脂结合位点来检查PkPSD的脂质调节。第三个具体目标将调查的假设,脂质调节PkPSD是机械耦合到酶原加工诱导构象变化的酶,激活或抑制蛋白酶功能。从这些研究中,我们将获得一个全面的看法,如何变构的细胞膜的脂质组成影响磷脂合成中的一种必需酶的激活。了解这方面的PSD调节耦合膜脂质组合物将有重要的后果,在磷脂代谢的病原体和哺乳动物细胞的生长不受管制的干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS R. VOELKER其他文献
DENNIS R. VOELKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS R. VOELKER', 18)}}的其他基金
Pulmonary Surfactant Antagonists of Rhinovirus Infection and Inflammation
鼻病毒感染和炎症的肺表面活性剂拮抗剂
- 批准号:
10246164 - 财政年份:2017
- 资助金额:
$ 30.43万 - 项目类别:
Defining Molecular Phenotypes of Exacerbation Prone Asthmatics
定义易加重哮喘的分子表型
- 批准号:
9766939 - 财政年份:2017
- 资助金额:
$ 30.43万 - 项目类别:
Pulmonary Surfactant Antagonists of Rhinovirus Infection and Inflammation
鼻病毒感染和炎症的肺表面活性剂拮抗剂
- 批准号:
9359965 - 财政年份:2017
- 资助金额:
$ 30.43万 - 项目类别:
Surfactant Lipid and Protein Inhibition of Rhinovirus Infections
表面活性剂脂质和蛋白质对鼻病毒感染的抑制作用
- 批准号:
10261955 - 财政年份:2016
- 资助金额:
$ 30.43万 - 项目类别:
Surfactant Lipid and Protein Inhibition of Rhinovirus Infections
表面活性剂脂质和蛋白质对鼻病毒感染的抑制作用
- 批准号:
10661665 - 财政年份:2016
- 资助金额:
$ 30.43万 - 项目类别:
Surfactant Lipid and Protein Inhibition of Rhinovirus Infections
表面活性剂脂质和蛋白质对鼻病毒感染的抑制作用
- 批准号:
10473854 - 财政年份:2016
- 资助金额:
$ 30.43万 - 项目类别:
Structure and Function of Eukaryotic Phosphatidylserine Decarboxylase
真核磷脂酰丝氨酸脱羧酶的结构和功能
- 批准号:
8579734 - 财政年份:2013
- 资助金额:
$ 30.43万 - 项目类别:
Structure and Function of Eukaryotic Phosphatidylserine Decarboxylase
真核磷脂酰丝氨酸脱羧酶的结构和功能
- 批准号:
9114599 - 财政年份:2013
- 资助金额:
$ 30.43万 - 项目类别:
Structure and Function of Eukaryotic Phosphatidylserine Decarboxylase
真核磷脂酰丝氨酸脱羧酶的结构和功能
- 批准号:
8899596 - 财政年份:2013
- 资助金额:
$ 30.43万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.43万 - 项目类别:
Research Grant














{{item.name}}会员




